Implant stability of narrow diameter implants in hyperglycemic patients-A 3-month case-control study.

T2DM narrow-diameter implants osseointegration resonance frequency analysis

Journal

Clinical and experimental dental research
ISSN: 2057-4347
Titre abrégé: Clin Exp Dent Res
Pays: United States
ID NLM: 101692332

Informations de publication

Date de publication:
08 2022
Historique:
revised: 19 04 2022
received: 17 07 2021
accepted: 27 04 2022
pubmed: 18 5 2022
medline: 19 8 2022
entrez: 17 5 2022
Statut: ppublish

Résumé

The aim of this prospective case-control study was to compare the development of implant stability quotients of narrow diameter implants in patients with type 2 diabetes mellitus (T2DM) and healthy individuals within the first 3 months after implant insertion. Sixteen patients with T2DM (HbA1C > 6.5%) as test group and 16 nondiabetic patients (HbA1C < 5.9%) as the control group were evaluated. All patients received narrow-diameter tissue level implants in an edentulous area posterior to the canine. The implant stability was measured by means of resonance frequency analysis after 3 days, 7 days, 4 weeks, and 3 months postplacement. Statistical analysis of intergroup differences and correlation to HbA1c values and treated jaw was performed in PRISM 8. The means for implant stability quotients showed a significant increase between Day 3 and 3-month assessment in both groups. No significant differences between study groups and no correlation of implant stability to HbA1c were found. The present study shows encouraging clinical outcomes for narrow-diameter implants inserted in the posterior zone in patients with uncontrolled T2DM.

Identifiants

pubmed: 35578391
doi: 10.1002/cre2.587
pmc: PMC9382047
doi:

Substances chimiques

Dental Implants 0
Glycated Hemoglobin A 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

969-975

Informations de copyright

© 2022 The Authors. Clinical and Experimental Dental Research published by John Wiley & Sons Ltd.

Références

Dent Update. 2013 Jul-Aug;40(6):472-4, 476-8, 480
pubmed: 23971346
Clin Oral Investig. 2021 Dec;25(12):6707-6715
pubmed: 33939006
Clin Oral Implants Res. 2014 Feb;25(2):e109-13
pubmed: 23167282
Pathophysiology. 2004 Oct;11(2):63-67
pubmed: 15364115
Clin Oral Implants Res. 2018 Feb;29(2):139-154
pubmed: 28719032
Adv Ther. 2014 Aug;31(8):817-36
pubmed: 25069580
Int J Prosthodont. 1998 Sep-Oct;11(5):491-501
pubmed: 9922740
Clin Exp Dent Res. 2022 Aug;8(4):969-975
pubmed: 35578391
Clin Oral Investig. 2020 Jul;24(7):2477-2486
pubmed: 31701247
Periodontol 2000. 2019 Oct;81(1):76-90
pubmed: 31407434
J Periodontal Implant Sci. 2017 Apr;47(2):106-115
pubmed: 28462009
J Biomed Mater Res A. 2013 Mar;101(3):748-54
pubmed: 22941963
Clin Oral Implants Res. 2017 Nov;28(11):1325-1333
pubmed: 27683194
Evid Based Dent. 2014 Sep;15(3):87-8
pubmed: 25343397
J Oral Biol Craniofac Res. 2020 Oct-Dec;10(4):629-638
pubmed: 32983857
Int J Oral Maxillofac Implants. 2014;29 Suppl:43-54
pubmed: 24660189
Clin Oral Implants Res. 2013 Feb;24(2):128-34
pubmed: 22111960
Clin Implant Dent Relat Res. 2006;8(4):218-22
pubmed: 17100747
Biomed Res Int. 2018 May 15;2018:7201093
pubmed: 29862286
J Oral Implantol. 2019 Dec;45(6):503-508
pubmed: 31536434
Int J Prosthodont. 1993 Mar-Apr;6(2):95-105
pubmed: 8329101
Periodontol 2000. 2008;47:51-66
pubmed: 18412573
Front Endocrinol (Lausanne). 2018 Jan 24;9:6
pubmed: 29416527
Clin Oral Implants Res. 2018 Oct;29 Suppl 16:21-40
pubmed: 30328192
Clin Implant Dent Relat Res. 2019 Apr;21(2):284-291
pubmed: 30741470
J Oral Maxillofac Surg. 2012 Dec;70(12):2761-7
pubmed: 23010369
Behav Res Methods. 2007 May;39(2):175-91
pubmed: 17695343
Clin Implant Dent Relat Res. 2009 Dec;11(4):338-47
pubmed: 19438966
Clin Oral Implants Res. 2011 Apr;22(4):365-72
pubmed: 21561478
Acta Biomater. 2019 Jan 15;84:402-413
pubmed: 30508657
J Dent Res. 2009 Apr;88(4):367-71
pubmed: 19407159
J Oral Implantol. 2019 Aug;45(4):334-340
pubmed: 31042455
Nat Rev Endocrinol. 2016 Oct;12(10):616-22
pubmed: 27388988
Clin Oral Implants Res. 2013 Jan;24(1):13-9
pubmed: 22145978
Int J Oral Maxillofac Implants. 2009;24 Suppl:237-59
pubmed: 19885448

Auteurs

Daniel Diehl (D)

Department of Periodontology, School of Dentistry, Faculty of Health, Witten/Herdecke University, Witten, Germany.
Institute of Pharmacology and Toxicology, Center for Biomedical Education and Research (ZBAF), Faculty of Health, Witten/Herdecke University, Witten, Germany.

Marianna Winkler (M)

Department of Periodontology, School of Dentistry, Faculty of Health, Witten/Herdecke University, Witten, Germany.

Hakan Bilhan (H)

Department of Periodontology, School of Dentistry, Faculty of Health, Witten/Herdecke University, Witten, Germany.

Anton Friedmann (A)

Department of Periodontology, School of Dentistry, Faculty of Health, Witten/Herdecke University, Witten, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH